Literature DB >> 29472421

Mycobacterium ChelonaeDeveloping Multidrug Resistance.

Vinod Kumar Mannelli1, Manoj P Rai1, Divyesh Reddy Nemakayala2, Naga Preethi Kadiri1.   

Abstract

Mycobacterium chelonae is a rapidly growing mycobacterium which is known to respond well to standard antibiotic treatment regimen. There are no specific guidelines for treatment. Antibiotics are chosen based on the bacterial sensitivity. Here we present a 47-year-old man with hip replacement who developed bright red papular generalised skin lesions and bilateral hip abscess. On workup, it was confirmed that M. chelonae was the causative organism. He was given 8 weeks of antibiotics; however, there was worsening of the hip abscess on interval imaging. The progression was most likely due to M. chelonae developing antibiotic resistance. Physicians should be aware of the rising resistance of this organism, and guide antibiotic therapy based on bacterial sensitivity to yield better outcomes. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  drugs: infectious diseases; infections

Mesh:

Substances:

Year:  2018        PMID: 29472421      PMCID: PMC5847952          DOI: 10.1136/bcr-2017-222569

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  31 in total

1.  Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.

Authors:  J Halpern; A Biswas; A Cadwgan; B B Tan
Journal:  Clin Exp Dermatol       Date:  2010-04       Impact factor: 3.470

2.  Mycobacterium chelonae--a growing problem in soft tissue infection.

Authors:  Rod J Hay
Journal:  Curr Opin Infect Dis       Date:  2009-04       Impact factor: 4.915

3.  hsp65 PCR-restriction analysis (PRA) with capillary electrophoresis for species identification and differentiation of Mycobacterium kansasii and Mycobacterium chelonae-Mycobacterium abscessus group.

Authors:  Anna Sajduda; Anandi Martin; Françoise Portaels; Juan Carlos Palomino
Journal:  Int J Infect Dis       Date:  2012-01-11       Impact factor: 3.623

4.  Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.

Authors:  Faiza Mougari; Jade Loiseau; Nicolas Veziris; Christine Bernard; Béatrice Bercot; Wladimir Sougakoff; Vincent Jarlier; Laurent Raskine; Emmanuelle Cambau
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

5.  Cushing's syndrome presenting as disseminated cutaneous Mycobacterium chelonae infection.

Authors:  S R Haas; M B Hodge; R A Duncan
Journal:  Clin Infect Dis       Date:  2001-08-06       Impact factor: 9.079

Review 6.  Nontuberculous mycobacterial ocular and adnexal infections.

Authors:  Ramana S Moorthy; Shailaja Valluri; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2012 May-Jun       Impact factor: 6.048

7.  Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.

Authors:  Richard J Wallace; Barbara A Brown-Elliott; Christopher J Crist; Linda Mann; Rebecca W Wilson
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 8.  Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature.

Authors:  Albert J Eid; Elie F Berbari; Irene G Sia; Nancy L Wengenack; Douglas R Osmon; Raymund R Razonable
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

9.  Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom.

Authors:  Agnieszka Broda; Heather Jebbari; Kate Beaton; Sarah Mitchell; Francis Drobniewski
Journal:  J Clin Microbiol       Date:  2012-11-07       Impact factor: 5.948

10.  Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism.

Authors:  Cécile Vignal; Yann Guérardel; Laurent Kremer; Maryse Masson; Dominique Legrand; Joël Mazurier; Elisabeth Elass
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more
  1 in total

1.  Prosthetic joint infection of the hip and knee due to Mycobacterium species: A systematic review.

Authors:  Asep Santoso; Krisna Yuarno Phatama; Sholahuddin Rhatomy; Nicolaas Cyrillus Budhiparama
Journal:  World J Orthop       Date:  2022-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.